Within the conference, a resolution was accepted on calling for the support for urgent introduction into the clinical practice of the latest cancer therapy methods, including the use of anticancer viruses, that is already available in Latvia and is intensively and successfully being studied in Russia, Finland, the USA, Canada, Australia, and other countries.Resolution
Professor, Dr. habil. chem. Ivars Kalvins,
Corresponding Member, Latvian Academy of Sciences,
Director of Latvian Institute of Organic Synthesis: www.osi.lv,
author of Mildronate and Leakadine,
author of 550 publications, including patents,
Certificate and Golden Medal of World Intellectual Property Organisation (WIPO) for
long-term and highly productive work as an inventor.
“…Cancer virotherapy is one of the most promising modern cancer therapy methods. Therefore, the leading countries in the development of pharmaceutical products have largely involved in virological researches with the aim of finding the most effective and safest viruses with the ability to selectively destroy malignant cells. Nobody doubts any more that viruses are able to do it. Just like nobody doubts any more that Latvia through Rigvir has become the leader and, at the same time, the pioneer in virotherapy. The only question is – how much time will it take until some other viral anticancer medicines will join Rigvir. Clearer and stronger with every day, virotherapy is claimed around the world as one of the firm primary therapy types, that can be more effective, safer, and patient-caring than the cancer treatment methods known until now…”
It is Day 2 of the Eurasian Anticancer Conference: Prediction & Prevention in Modern Oncology.
The main event of the day was Professor I.Kalviņš's (from Latvia) report: VIROTHERAPY – TODAY'S REALITY AND PERSPECTIVES OF THE FUTURE and a roundtable discussion: “VIROTHERAPY IN ONCOLOGY” about Virotherapy with RIGVIR® and its role in the treatment of oncological diseases and immunity boosting.
Industry specialists from various countries took part in the roundtable discussion.
VIROTHERAPY… LATVIA’S PRIDE
After more than half a decade, Latvian scientists were finally able to hit huge success as they accomplished a break-through in cancer treatment through Virotherapy techniques rather than Chemotherapy; a success which will definitely have its big trace in history as Rivgir (the first ans so far the only) will change cancer treatment methods worldwide.
В Уфе прошла Евразийская противораковая конференция